Plantar Fasciitis Treatment Global Market Report 2025
상품코드:1821694
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
족저근막염 치료 시장 규모는 향후 수년간 비약적인 성장이 예상됩니다. 2029년에 CAGR은 22.6%를 나타낼 것으로 예측되고 46억 9,000만 달러로 성장할 전망입니다. 예측 기간 동안의 성장은 규제 변화 및 승인, 환자 중심 접근법, 연구 및 임상 시험, 맞춤형 의약품에 주력하는 점, 고령 인구 증가 등에 기인할 수 있습니다. 예측 기간의 주요 동향으로는 집중 재활 기술, 정형외과 기기 혁신, 바이오메카닉스 연구, 대체 요법 발전, 환자 교육 및 자가 관리 등이 포함됩니다.
향후 5년간 22.6% 성장이라는 전망치는 이전 예측 대비 0.2% 소폭 하락한 수치입니다. 이 하락은 주로 미국과 타국 간 관세 영향 때문입니다. 무역 긴장은 독일과 이탈리아에서 수입되는 체외 충격파 치료기 및 맞춤형 보조기 가격을 25-30% 상승시킬 수 있으며, 이는 환자 통증 관리 기간 연장 및 족부 클리닉 운영 비용 증가로 이어질 수 있습니다. 상호 관세 부과와 무역 긴장 및 제한 강화로 인한 전 세계 경제 및 무역에 대한 부정적 영향으로 그 영향은 더욱 광범위하게 될 것입니다.
비만 유병률 증가는 향후 족저근막염 시장을 촉진할 것으로 예상됩니다. 비만은 비정상적이거나 과도한 지방 축적으로 특징지어지는 건강 문제입니다. 체질량지수(BMI) 25 이상은 과체중으로 분류되며, BMI 30 이상은 비만으로 간주됩니다. 정상 체중을 가진 개인은 BMI 30 이상인 사람에 비해 족저근막염 발병 가능성이 거의 6배 낮습니다. 예를 들어, 미국 정부 기관인 질병통제예방센터(CDC)가 2022년에 발표한 자료에 따르면, 현재 22개 주에서 성인 비만 유병률이 35% 이상으로 보고되고 있으며, 이는 2021년 19개 주에서 증가한 수치입니다. 따라서 비만 증가가 족저근막염 시장 확장을 촉진하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 족저근막염 치료 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 족저근막염 치료 시장 : 성장률 분석
세계의 족저근막염 치료 시장 실적 : 규모와 성장(2019-2024년)
세계의 족저근막염 치료 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 족저근막염 치료 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 족저근막염 치료 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
약물요법
교정 기구
충격파 요법
수술
기타 유형
세계의 족저근막염 치료 시장 : 진단별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병력
신체 검사
X선
엑스레이 검사
기타 진단
세계의 족저근막염 치료 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
클리닉
기타 최종 사용자
세계의 족저근막염 치료 시장, 약물요법 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
비스테로이드성 항염증제(NSAIDs)
코르티코스테로이드
진통제
국소 치료
세계의 족저근막염 치료 시장, 교정 기구 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
맞춤형 교정 인서트
시판 인서트
야간 교정기
뒷발꿈치 보호대
세계의 족저근막염 치료 시장, 충격파 요법 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
방사상 충격파요법
집중 충격파요법
세계의 족저근막염 치료 시장, 수술 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
발바닥 근막 이완
비복근 후퇴
기타 외과 수술
세계의 족저근막염 치료 시장, 기타 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
물리 치료
마사지 치료
스트레칭 및 근력 강화 운동
대체요법
제7장 지역별 및 국가별 분석
세계의 족저근막염 치료 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 족저근막염 치료 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
족저근막염 치료 시장 : 경쟁 구도
족저근막염 치료 시장 : 기업 프로파일
Bayer AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Superfeet Worldwide LLC : 개요, 제품 및 서비스, 전략 및 재무 분석
Bauerfeind AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Ottobock SE & Co. KGaA : 개요, 제품 및 서비스, 전략 및 재무 분석
Shapecrunch Technology Pvt. Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Sanofi SA
Eli Lilly and Company
GlaxoSmithKline plc
Pfizer Inc.
Bristol-Myers Squibb Company
F. Hoffmann-La Roche Ltd.
Scholl's Wellness Co.
Hanger Inc.
Merck & Co. Inc.
Johnson & Johnson Services Inc.
Smith & Nephew plc
Arthrex Inc.
DJO Global Co.
Medline Industries Inc.
Bird & Cronin Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
족저근막염 치료 시장(2029년) : 새로운 기회를 제공하는 국가
족저근막염 치료 시장(2029년) : 새로운 기회를 제공하는 부문
족저근막염 치료 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
Plantar fasciitis treatment involves medical care or preventive measures aimed at assessing the occurrence and frequency of a degenerative condition affecting the thick band of tissue at the base of the foot. An integral aspect of treating plantar fasciitis is physical therapy.
The primary categories of plantar fasciitis treatment include medication therapy, orthotics, shockwave therapy, surgery, and other interventions. Medication therapy involves treating the condition using prescription or non-prescription medicines, over-the-counter medications, and herbal remedies. Diagnosis typically relies on medical history, physical examination, X-rays, radiography, and other diagnostic methods and is administered by hospitals, clinics, and other healthcare providers.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The plantar fasciitis treatment market research report is one of a series of new reports from The Business Research Company that provides plantar fasciitis treatment market statistics, including plantar fasciitis treatment industry global market size, regional shares, competitors with a plantar fasciitis treatment market share, detailed plantar fasciitis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the plantar fasciitis treatment industry. This plantar fasciitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The plantar fasciitis treatment market size has grown exponentially in recent years. It will grow from $1.68 billion in 2024 to $2.07 billion in 2025 at a compound annual growth rate (CAGR) of 23.7%. The growth in the historic period can be attributed to alternative therapies, patient education and awareness, pain management solutions, rise in sports injuries, physical therapy techniques.
The plantar fasciitis treatment market size is expected to see exponential growth in the next few years. It will grow to $4.69 billion in 2029 at a compound annual growth rate (CAGR) of 22.6%. The growth in the forecast period can be attributed to regulatory changes and approvals, patient-centric approaches, research and clinical trials, focus on personalized medicine, growing aging population. Major trends in the forecast period include focused rehabilitation techniques, innovations in orthopedic devices, biomechanical studies, alternative therapies advancements, patient education and self-care.
The forecast of 22.6% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could inflate prices of extracorporeal shockwave therapy machines and custom orthotics imported from Germany and Italy by 25-30%, resulting in prolonged patient pain management and higher podiatry clinic operational expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing prevalence of obesity is expected to drive the growth of the plantar fasciitis market in the future. Obesity is a health concern characterized by an abnormal or excessive accumulation of fat. A body mass index (BMI) of 25 or greater is classified as overweight, while a BMI above 30 is considered obese. Individuals with a normal weight have nearly six times lower chances of developing plantar fasciitis compared to those with a BMI of 30 or higher. For example, data released in 2022 by the Centers for Disease Control and Prevention (CDC), a US government agency, shows that 22 states now report an adult obesity prevalence of 35% or higher, an increase from 19 states in 2021. Thus, the rise in obesity is driving the expansion of the plantar fasciitis market.
The growth of the plantar fasciitis treatment market is anticipated to be propelled by the rising prevalence of diabetes. Diabetes, characterized by elevated blood sugar levels, leads to complications such as foot pain and discomfort due to inflammation of the plantar fascia. Plantar fasciitis treatment in diabetes aims to alleviate these symptoms, enhance mobility, and reduce the risk of complications. The IDF Diabetes Atlas reported in 2021 that globally, 537 million people were affected by diabetes, with an estimated 643 million individuals projected to be impacted by 2030 and a significant increase to 783 million by 2045. This surge in diabetes cases is a major driver for the plantar fasciitis treatment market.
Technological advancements are emerging as a prominent trend in the plantar fasciitis treatment market. Leading companies in the market are actively developing and implementing innovative technologies to transform the treatment landscape for plantar heel pain. In December 2022, ZetrOZ Systems introduced the Sam X1, a wireless ultrasound device with FDA certification for at-home usage, offering a regenerative treatment alternative for soft tissue injuries and plantar fasciitis. This device, proven effective in treating various injuries, widens blood vessels to enhance blood flow, promoting healing without drugs or surgery.
Major companies in the plantar fasciitis treatment market are focusing on technological initiatives such as dedicated platforms for accessing global 3D foot scan data. Aetrex, a US-based foot technology company, launched the Foot.com Data Portal in September 2022, providing footwear brands with comprehensive 3D foot scan data to enhance the development of better-fitting shoes. The portal, supported by Aetrex's foot scanners, Albert 2 Pro and Albert 3DFit, offers accurate measurements and assists brands in improving the design of anatomically correct lasts for enhanced comfort and performance.
In October 2022, Patient Square Capital's acquisition of Hanger Inc. for approximately $1.25 billion is a noteworthy development in the plantar fasciitis treatment market. This acquisition is expected to support Hanger in future growth initiatives, particularly in providing innovative and high-quality care through its medical devices, including ankle-foot orthoses (AFO) used in the treatment of plantar fasciitis.
Major companies operating in the plantar fasciitis treatment market include Bayer AG, Superfeet Worldwide LLC, Bauerfeind AG, Ottobock SE & Co. KGaA, Shapecrunch Technology Pvt. Ltd., Sanofi SA, Eli Lilly and Company, GlaxoSmithKline plc, Pfizer Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Scholl's Wellness Co., Hanger Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., Smith & Nephew plc, Arthrex Inc., DJO Global Co., Medline Industries Inc., Bird & Cronin Inc., Aetrex Worldwide Inc.
North America was the largest region in the plantar fasciitis treatment market in 2024. The regions covered in the plantar fasciitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the plantar fasciitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The plantar fasciitis treatment market includes revenues earned by entities by provide extracorporeal shock wave therapy (ESWT), intracorporeal pneumatic shock wave therapy (IPST), inflammation-related pain drugs, and non-operative treatments. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Plantar Fasciitis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on plantar fasciitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for plantar fasciitis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The plantar fasciitis treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Medication Therapy; Orthotics; Shockwave Therapy; Surgery; Other Types
2) By Diagnosis: Medical History; Physical Examination; X-Rays; Radiography; Other Diagnosis
3) By End User: Hospitals; Clinics; Other End Users
3. Plantar Fasciitis Treatment Market Trends And Strategies
4. Plantar Fasciitis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Plantar Fasciitis Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Plantar Fasciitis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Plantar Fasciitis Treatment Market Growth Rate Analysis
5.4. Global Plantar Fasciitis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Plantar Fasciitis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Plantar Fasciitis Treatment Total Addressable Market (TAM)
6.1. Global Plantar Fasciitis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medication Therapy
Orthotics
Shockwave Therapy
Surgery
Other Types
6.2. Global Plantar Fasciitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medical History
Physical Examination
X-Rays
Radiography
Other Diagnosis
6.3. Global Plantar Fasciitis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Other End Users
6.4. Global Plantar Fasciitis Treatment Market, Sub-Segmentation Of Medication Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Corticosteroids
Pain Relievers
Topical Treatments
6.5. Global Plantar Fasciitis Treatment Market, Sub-Segmentation Of Orthotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Custom Orthotic Inserts
Over-The-Counter Insoles
Night Splints
Heel Cups
6.6. Global Plantar Fasciitis Treatment Market, Sub-Segmentation Of Shockwave Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Radial Shockwave Therapy
Focused Shockwave Therapy
6.7. Global Plantar Fasciitis Treatment Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Plantar Fascia Release
Gastrocnemius Recession
Other Surgical Procedures
6.8. Global Plantar Fasciitis Treatment Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Physical Therapy
Massage Therapy
Stretching And Strengthening Exercises
Alternative Therapies
7. Plantar Fasciitis Treatment Market Regional And Country Analysis
7.1. Global Plantar Fasciitis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Plantar Fasciitis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
